Recent Headlines
Within Biotechnology
Microvascular Therapeutics Receives NIH SBIR Phase I Funds for Its Program to Treat Heart Attack
Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health. Wyatt Unger, MD, MBA, President and CEO of... - July 31, 2020 - Microvascular Therapeutics, Inc.
Locus FS Replaces Chemicals and Improves Sustainability in CPG Market with Launch of Performance Ingredients Company
Locus Fermentation Solutions is expanding its award-winning green technology into the Consumer Packaged Goods market with the launch of a new operating company, Locus Performance Ingredients that will replace toxic and palm-based chemicals and maximize product sustainability. - July 22, 2020 - Locus Performance Ingredients
Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.
Hyperion Biotechnology's Legionella Water Testing Services Can Help Businesses Reopen Safely
Coronavirus is not the only concern for business owners as they reopen. Another threat to health safety is water-borne bacteria called Legionella. - July 17, 2020 - Hyperion Biotechnology, Inc.
EUPROTEIN Launched the Supreme Humanly-Expressed Proteins to Help Research in SARS-CoV-2
EUPROTEIN Inc., the expert in mammalian expressed protein, has launched the full set of their top-quality recombinant proteins to help researchers around the world for their studies towards this global pandemic. These protein are expressed in human mammalian cells, which inherently is of superior quality compared to those expressed from E. Coli. - July 09, 2020 - EUPROTEIN Inc.
3 Bros Grow Announces Vertically Integrated Cannabis Genetics Nursery
The 3 Bros Grow, a vertically integrated cannabis company, is moving into their first phase of greenhouse nursery to provide clean secured genetics, clones and teens to their operations. Luck #7, Cherry Bomb, Twizzlas, Grease Monkey and Chocolatina are some of the exclusive genetics available only from 3 Bros Grow. - July 01, 2020 - 3 Bros Grow
40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI
Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from Cayman’s Women in Research program this year. - July 01, 2020 - Cayman Chemical Company
R3 International Now Offering Stem Cell Therapy for Coronavirus in Mexico
R3 Stem Cell International is now offering stem cell therapy for coronavirus patients at its first rate Center in Tijuana, Mexico. Several treatment options are available that include up to 200 million stem cells, with pricing starting at only $2975. A growing body of research out of Europe,... - June 30, 2020 - R3 Stem Cell
On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene
The ALS Therapy Development Institute (ALS TDI) is excited to announce that on Thursday, June 25, they will be hosting the second episode of their new “How I Brewed This: Craft Brewer Series,” featuring Kevin Smith of Bale Breaker Brewing Company and Mike Smith of B.T. Loftus... - June 20, 2020 - ALS Therapy Development Institute
AdvantaPure(R) Now Offers GORE(R) STA-PURE(R) Pump Tubing, an Industry Staple for Single-Use Biotech and Pharmaceutical Processes
AdvantaPure is now a systems integrator of GORE STA-PURE Pump Tubing, Series PCS. The AdvantaPure team is expert at molding connections for tubing assemblies and can overmold GORE STA-PURE Pump Tubing as the pump element in biopharm and pharmaceutical assemblies. The overmolding process results in a smooth contact surface for optimal fluid flow. GORE STA-PURE Pump Tubing connects to any of AdvantaPure’s AdvantaSil(R) platinum-cured silicone tubing using overmolding technology. - June 17, 2020 - AdvantaPure
Bactronix Franchise Push Sees Unprecedented Success in Marketplace
Bactronix, a science based microbial control company headquartered in Pennsylvania, has seen explosive growth since their latest franchise push announcement this spring. The company, specializing in environmentally safe, non-toxic sanitizing products and hospital-grade disinfection services, has... - June 11, 2020 - Bactronix
Bio Bench is Cooperating with Helixar Biosciences for the Europe and US Market
Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development. - June 09, 2020 - Bio Bench
Vascular BioSciences Announces New Preclinical Research Results Demonstrating Improved Pulmonary Hypertension and Sepsis Survival with CAR Peptide
CEO of Vascular BioSciences, David Mann, makes connection between current research and COVID-19 applications. - June 05, 2020 - Vascular BioSciences, Inc
AB BIOINNOVATIONS, Inc. Announces a Ground-Breaking Alternative to Antibiotics
The AB BIOINNOVATIONS, Inc. Antibacterial and Anti-inflammatory strips 1. Immediately resolve the very infection (including antibiotic-resistant bacteria), which its color indicator has detected; 2. AB BIO compound also immediately addresses inflammation at the site, thus suppressing pain, swelling, and discomfort. - June 03, 2020 - AB BIOINNOVATIONS, Inc.
Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC
Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
Minus K Technology Releases Its New CT-2 Ultra-Thin, Low-Frequency Passive Vibration Isolator
Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.
Fast Track MHRA Approval for Vicore Pharma’s COVID-19 Clinical Trial Received in Record Time
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection. - May 04, 2020 - Orphan Reach
ALS TDI Hosts “Gamers vs. ALS” Virtual Livestream Event to Benefit Critical ALS Research
Gamers can join the livestream video game event on Tiltify, May 3-9, to raise funds for cutting-edge ALS research at the ALS Therapy Development Institute. - May 03, 2020 - ALS Therapy Development Institute
New COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing - April 30, 2020 - Life Science Strategy Group, LLC
My-State Trek Virtual Event Provides New Opportunity to Support ALS Research While Social Distancing
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020 - ALS Therapy Development Institute
Virun and East West Bank Partner-Up to Save Lives
VIRUN Nutra-biosciences was able to get fully funded with the help of East West Bank. VIRUN manufactures food products and dietary supplements and are considered part of the essential workforce. Virun makes immune boosting products such as liposomal Vitamin C and patented, clinically proven Glutathione Tripeptides bound to Lactoferrin that have shown success in trials toward innate immunity. - April 22, 2020 - VIRUN
3 Bros Grow Announces Compassion Program During COVID-19
The 3 Bros Santa Cruz dispensary is currently running a compassion program during the COVID-19 outbreak and Shelter in Place orders. As an essential business and being allowed to remain open to serve the community for cannabis products such as cannabis flower, pre-rolls, edibles, topicals and... - April 18, 2020 - 3 Bros Grow
New Treatment Shows Vision Benefit in Age Related Macular Degeneration
MD Stem Cells reports results for Dry AMD from their clinical study SCOTS - the Stem Cell Ophthalmology Treatment Study. 63% of treated and evaluated eyes achieved improvement in vision while an additional 34% had vision remain stable in follow up. No complications occurred. Results were statistically significant. - April 18, 2020 - MD Stem Cells
Aciont's Paper, "Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules" Published in JOPT
Aciont Inc. announced today that results from preclinical studies of its Visulex-I technology is published online ahead of print in the Journal of Ocular Pharmacology and Therapeutics under the title “Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of... - April 18, 2020 - Aciont Inc.
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
Cellix Bio Pharma Initiates Acquisition of Avaca Pharma: Formulation Development CRO
Cellix Bio Pharma, a global contract research organization (CRO), transforms today’s healthcare challenges into tomorrow’s solutions. Cellix Bio Pharma is an experienced CRO focused on development of pharmaceutical formulations. Cellix Bio Pharma focuses to combine the AI computational power to the chemical and biological space in order to streamline drug discovery, design, development, and optimization that can expedite drug development. - April 10, 2020 - Cellix Bio Pharma Private Limited
ATEX Certified Raman Analyzer Now Available from Tornado Spectral Systems
OPIS 35 Provides “Inherently Safe” Laser Radiation for Zone 0 Hazardous Location - March 13, 2020 - Tornado Spectral Systems
Rare Diseases Research Funded by $220,000 in Grants from CABRI
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching... - March 12, 2020 - Cayman Chemical Company
Epitope Diagnostics Has Proudly Introduced Immunoassay Kits Exclusively for the Qualitative Detection of COVID-19
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
Announcing Vegan Skincare Products from Moongate Botanicals
Sharon Yancey founded Moongate Botanicals in Austin, Texas after struggling to find products that matched her lifestyle. Moongate Botanicals skincare products are vegan, cruelty-free, and eco-friendly. These products do not contain petroleum-based ingredients, harmful chemicals, and synthetic fragrances. - March 03, 2020 - Moongate Botanicals
Clinical Guidelines for Physical Therapy in Huntington Disease
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group
Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and Organ Production
Recombinetics (RCI) today announced a collaborative research project with University of Texas Southwestern (UTSW) to identify key factors that improve the efficiency of generating interspecies chimera between pigs and humans. This near-term goal will benefit the long-term objective of advancing... - February 27, 2020 - Recombinetics, Inc.
BioStat Solutions, Inc. Promotes Dr. Lin Li to Senior Director of Scientific Operations
BioStat Solutions, Inc. (BSSI), a data analytics company providing consulting services to pharmaceutical and biotechnology companies, announced today the promotion of Dr. Lin Li to Senior Director of Scientific Operations. He will have increased responsibility leading the scientific team and... - February 10, 2020 - BioStat Solutions, Inc.
MedBiome Licenses the RapidAIM Technology Targeting the Microbiome to Improve Human Health
MedBiome accelerates the development of drugs targeting the gut microbiome. The RapidAIM technology enables rapid screening of the effects of compounds on live individual human microbiomes in 96 well plates. - January 30, 2020 - MedBiome
MoBiTec to Offer Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit
Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit is used for the qualitative detection of a novel coronavirus, identified in 2019 in Wuhan City, China, in respiratory tract specimens by real time PCR systems. - January 25, 2020 - MoBiTec GmbH
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
The International Division of The MAGIC Foundation®, ICOSEP Welcomes MAGIC Africa to Their Network
ICOSEP welcomes MAGIC Africa to their network of organizations. The network is comprised of patient organizations, professional societies and volunteers, who are uniting their voices for endocrine awareness. - January 17, 2020 - ICOSEP
3Sixty Pharma Solutions Partners with Westchester Biotech Project
Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists - January 11, 2020 - 3Sixty Pharma Solutions
New NF-kB Panel of Antibodies from AbboMax and Human Diseases
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019 - ALS Therapy Development Institute
3Sixty Pharma Solutions Announces Successful Submission of Start-Up Biotech Investigational New Drug Application
3Sixty Pharma Solutions LLC, www.3sixtypharma.com, last week announced the successful submission to FDA of its first Investigational New Drug (IND) Application on behalf of one of its start-up biotech clients. This news comes on the heels of the formal organization in 2018 of 3Sixty Pharma... - December 16, 2019 - 3Sixty Pharma Solutions
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019 - ALS Therapy Development Institute
BoneScience Will Soon Launch Its Newly Developed Product Dr’s Grow UP
The teenage years are an important and exciting time in our life. Our body goes through a lot of change and emotions play an important role. Body height, as well as physical appearance, become often important factors for teen self-esteem. They take influence on friendships, school, and dating... - December 09, 2019 - Redmars America Co., Ltd.
Virun® Making an Impact at PGA Show January 2020
Virun® will be amongst the 1,000+ interactive exhibitors attending the PGA Merchandise Show in Orlando, Florida January 21 through January 24. - December 06, 2019 - VIRUN
RetroMAD1, the World's First Antiviral Protein, Saves Cats Suffering from Feline Leukemia, a Disease Once Thought Incurable
Biovalence Technologies owns a proprietary recombinant proteomic technology platform that covers around 100 different proteins with potential antiviral therapeutic. The company’s mission is to save lives by applying recent advancement in genomics and proteomics on infectious diseases that have no cure today. - December 05, 2019 - Biovalence Technologies Pte Ltd
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
AMT Introduces UriCap for Patients in Long-Term Care - Innovative External Urine Collection Device Improves Quality of Care and Reduce Facility Costs
American Medical Technologies (AMT), the leading independent provider of wound care solutions for long-term care and post-acute environments, has partnered with TillaCare to introduce UriCap, an innovative external urine collection device for managing female urinary incontinence (UI) in the... - November 23, 2019 - American Medical Technologies